• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wheels Up Announces Gregory Summe to Join Board of Directors

    8/8/24 8:05:00 AM ET
    $AVTR
    $GRAL
    $NXPI
    $STT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Medical Specialities
    Health Care
    Get the next $AVTR alert in real time by email

    Veteran Leader Brings Deep Strategic, Aviation, and Governance Experience to Boardroom

    ATLANTA, Aug. 8, 2024 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) today announced that Gregory L. Summe, Managing Partner of Glen Capital Partners LLC, joined its Board of Directors, effective August 7.

    Wheels Up (PRNewsfoto/Wheels Up)

    Summe fills the unexpired term of David Adelman, who is stepping down to focus on other professional pursuits. Summe's initial term as a Class II director will continue until the 2026 annual meeting of the Company's stockholders. He will serve on the Audit and Compensation Committees of the Board.

    "We are excited to welcome Greg Summe to our Board of Directors. He brings sharp strategic focus, decades of relevant experience, a successful track record as a public company CEO, and valuable insights as an investor and highly experienced corporate director," said Adam Zirkin, Chairman of the Board. "I would also like to thank David Adelman for his years of invaluable service and unwavering dedication to the Wheels Up mission."

    Summe currently serves as the Managing Partner of Glen Capital, a role which he has held since 2013. Previously, Summe was the Managing Director and Vice Chair of Global Buyout at The Carlyle Group ("Carlyle"), a leading global private equity firm, from 2009 to 2014. At Carlyle, he was a member of the firm's Operating Committee and responsible for the Buyout Funds in Financial Services, Infrastructure, Japan, the Middle East and Africa. Prior to joining Carlyle, he was the Chair and Chief Executive Officer of PerkinElmer Inc. ("PerkinElmer"), a global leader in health sciences, from 1998 to 2009. He also served as a senior advisor to Goldman Sachs Capital Partners, from 2008 to 2009. Prior to joining PerkinElmer, Summe held various leadership roles, including as President of General Aviation Avionics, President of the Aerospace Engines Group and President of the Automotive Products Group of AlliedSignal, now Honeywell International, General Manager of Commercial Motors at General Electric Company, and Partner with the global consulting firm McKinsey & Company, Inc.

    Summe is a deeply experienced corporate director, having served on 11 public boards over the span of his 23 years as a corporate director, including in board and committee leadership roles, and has served on the Board of Directors of State Street Corporation (NYSE:STT) since 2001, NXP Semiconductors NV (NASDAQ:NXPI) since 2015, Avantor Inc. (NYSE:AVTR) since 2020, and Grail, Inc. (NASDAQ:GRAL) since 2024.

    Summe received his Bachelor of Science and Master of Science degree in Electrical Engineering from the University of Kentucky and the University of Cincinnati, respectively, and a Master of Business Administration with distinction from the Wharton School at the University of Pennsylvania. He is also in the University of Kentucky's Hall of Distinction.

    About Wheels Up

    Wheels Up is a leading provider of on-demand private aviation and one of the largest companies in the industry. Wheels Up offers a complete global aviation solution with a large and diverse fleet and a global network of safety-vetted charter operators, all backed by an uncompromising commitment to safety and service. Customers can access charter and membership programs, as well as unique commercial travel benefits through a one-of-a-kind, strategic partnership with Delta Air Lines. Wheels Up also offers cargo, safety and security solutions and managed services to individuals, industry, government and civil organizations.

    Wheels Up is guided by the mission to deliver a premium solution for every customer journey. With the Wheels Up mobile app and website, members and customers have the digital convenience to search, book and fly.

    For more information, please visit: wheelsup.com

    Media Contact

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/wheels-up-announces-gregory-summe-to-join-board-of-directors-302217239.html

    SOURCE Wheels Up

    Get the next $AVTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVTR
    $GRAL
    $NXPI
    $STT

    CompanyDatePrice TargetRatingAnalyst
    State Street Corporation
    $STT
    2/23/2026$150.00Buy
    Citigroup
    GRAIL Inc.
    $GRAL
    2/19/2026$114.00Hold
    TD Cowen
    GRAIL Inc.
    $GRAL
    2/17/2026$113.00Outperform
    Robert W. Baird
    State Street Corporation
    $STT
    1/7/2026$138.00Buy → Hold
    Truist
    State Street Corporation
    $STT
    1/5/2026$152.00Overweight → Equal Weight
    Barclays
    Avantor Inc.
    $AVTR
    1/5/2026$12.00Outperform → In-line
    Evercore ISI
    Avantor Inc.
    $AVTR
    12/17/2025$9.00Hold → Underperform
    Jefferies
    Avantor Inc.
    $AVTR
    12/15/2025$13.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $AVTR
    $GRAL
    $NXPI
    $STT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on State Street with a new price target

    Citigroup resumed coverage of State Street with a rating of Buy and set a new price target of $150.00

    2/23/26 8:40:01 AM ET
    $STT
    Major Banks
    Finance

    TD Cowen initiated coverage on GRAIL with a new price target

    TD Cowen initiated coverage of GRAIL with a rating of Hold and set a new price target of $114.00

    2/19/26 7:51:30 AM ET
    $GRAL
    Medical Specialities
    Health Care

    Robert W. Baird initiated coverage on GRAIL with a new price target

    Robert W. Baird initiated coverage of GRAIL with a rating of Outperform and set a new price target of $113.00

    2/17/26 8:18:22 AM ET
    $GRAL
    Medical Specialities
    Health Care

    $AVTR
    $GRAL
    $NXPI
    $STT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Summe Gregory L bought $940,000 worth of shares (100,000 units at $9.40) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/12/26 5:24:47 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Mehra Sanjeev K was granted 8,106 shares and bought $3,881,500 worth of shares (350,000 units at $11.09) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    12/9/25 5:11:24 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chair Southern Julie bought $50,733 worth of shares (225 units at $225.48), increasing direct ownership by 2% to 11,937 units (SEC Form 4)

    4 - NXP Semiconductors N.V. (0001413447) (Issuer)

    12/5/25 6:14:15 AM ET
    $NXPI
    Semiconductors
    Technology

    $AVTR
    $GRAL
    $NXPI
    $STT
    SEC Filings

    View All

    SEC Form 10-K filed by State Street Corporation

    10-K - STATE STREET CORP (0000093751) (Filer)

    2/19/26 4:31:31 PM ET
    $STT
    Major Banks
    Finance

    GRAIL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - GRAIL, Inc. (0001699031) (Filer)

    2/19/26 4:18:30 PM ET
    $GRAL
    Medical Specialities
    Health Care

    Wheels Up Experience Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Wheels Up Experience Inc. (0001819516) (Filer)

    2/19/26 6:56:40 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    $AVTR
    $GRAL
    $NXPI
    $STT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and COO Tahiri Mostapha was granted 10,193 shares and covered exercise/tax liability with 3,908 shares, increasing direct ownership by 12% to 59,994 units (SEC Form 4)

    4 - STATE STREET CORP (0000093751) (Issuer)

    2/18/26 4:04:23 PM ET
    $STT
    Major Banks
    Finance

    EVP; Gen Counsel and Secretary Shelton Mark covered exercise/tax liability with 2,529 shares, decreasing direct ownership by 9% to 24,441 units (SEC Form 4)

    4 - STATE STREET CORP (0000093751) (Issuer)

    2/18/26 4:04:08 PM ET
    $STT
    Major Banks
    Finance

    Executive Vice President Horgan Kathryn M was granted 16,950 shares and covered exercise/tax liability with 11,565 shares, increasing direct ownership by 5% to 110,363 units (SEC Form 4)

    4 - STATE STREET CORP (0000093751) (Issuer)

    2/18/26 4:04:16 PM ET
    $STT
    Major Banks
    Finance

    $AVTR
    $GRAL
    $NXPI
    $STT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    State Street Corporation Declares Dividends on its Common Stock and Non-Cumulative Perpetual Preferred Stock Series "G," "I," "J," and "K"

    State Street Corporation (NYSE:STT) today announced a quarterly cash dividend of $0.84 per share of common stock, payable on April 13, 2026 to common shareholders of record at the close of business on April 1, 2026. Additionally, State Street Corporation announced a cash dividend on each of the below outstanding series of non-cumulative perpetual preferred stock: Series G (represented by depositary shares, each representing a 1/4000th interest in a share of Series G preferred stock). The cash dividend is in the amount of $1,337.50 per share of Series G preferred stock (resulting in a distribution of approximately $0.334375 per depositary share) and is payable on March 16, 2026 to the h

    2/19/26 4:30:00 PM ET
    $STT
    Major Banks
    Finance

    GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results

    Sold More Than 185,000 Galleri® Tests in 2025, Growing U.S. Galleri Revenue 26% Year-Over-Year to $136.8 MillionCompleted Galleri PMA Submission to FDAShared Topline Results from the NHS-Galleri TrialCompleted Analysis of the Full 35k Participant PATHFINDER 2 StudyStrong Financial Position with Cash into 2030MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (NASDAQ:GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the fourth quarter and full year 2025 and provided business updates.

    2/19/26 4:02:00 PM ET
    $GRAL
    Medical Specialities
    Health Care

    Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate

    The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over TimeGRAIL Announces U.S. Sales Force Expansion Based on Strong NHS-Galleri and PATHFINDER 2 Trial ResultsMENLO PARK, Calif. and LONDON, Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (NASDAQ:GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced topline results from the landmark, randomized, controlled NHS-Galleri trial, which evaluated annual multi-cancer screening with the Galleri® test in England's National Health Service (NHS) over three years in 142,000 demographically representative participants aged 50

    2/19/26 4:01:00 PM ET
    $GRAL
    Medical Specialities
    Health Care

    $AVTR
    $GRAL
    $NXPI
    $STT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Wheels Up Experience Inc.

    SC 13D/A - Wheels Up Experience Inc. (0001819516) (Subject)

    11/14/24 4:30:05 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    SEC Form SC 13G filed by GRAIL Inc.

    SC 13G - GRAIL, Inc. (0001699031) (Subject)

    11/14/24 3:35:14 PM ET
    $GRAL
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Avantor Inc.

    SC 13G/A - Avantor, Inc. (0001722482) (Subject)

    11/14/24 1:28:33 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AVTR
    $GRAL
    $NXPI
    $STT
    Leadership Updates

    Live Leadership Updates

    View All

    Avantor® Appoints Simon Dingemans to its Board of Directors

    RADNOR, Pa., Dec. 18, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Simon Dingemans to its Board of Directors, effective January 2, 2026. Mr. Dingemans is an accomplished executive with extensive global leadership experience across healthcare, finance and strategic business transformation. He was previously the Chief Financial Officer of GlaxoSmithKline plc, a Partner at Goldman Sachs, and a Managing Dire

    12/18/25 8:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Avantor® Appoints Sanjeev Mehra to its Board of Directors

    RADNOR, Pa., Dec. 4, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Sanjeev Mehra to its Board of Directors, effective immediately.   Mr. Mehra is Co-Founder and serves as Managing Partner of Periphas Capital LP, a private equity firm focused on investing in technology enabled businesses in services, consumer and industrial end markets. Prior to founding Periphas, Mr. Mehra spent over 30 years at Goldman,

    12/4/25 4:15:00 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer

    RADNOR, Pa., Nov. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Mary Blenn has been appointed to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Ms. Blenn will report to President and CEO Emmanuel Ligner and will lead the Company's manufacturing and supply chain operations. She will be responsible for aligning Avantor's manufacturing and logistics network wit

    11/10/25 8:30:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AVTR
    $GRAL
    $NXPI
    $STT
    Financials

    Live finance-specific insights

    View All

    State Street Corporation Declares Dividends on its Common Stock and Non-Cumulative Perpetual Preferred Stock Series "G," "I," "J," and "K"

    State Street Corporation (NYSE:STT) today announced a quarterly cash dividend of $0.84 per share of common stock, payable on April 13, 2026 to common shareholders of record at the close of business on April 1, 2026. Additionally, State Street Corporation announced a cash dividend on each of the below outstanding series of non-cumulative perpetual preferred stock: Series G (represented by depositary shares, each representing a 1/4000th interest in a share of Series G preferred stock). The cash dividend is in the amount of $1,337.50 per share of Series G preferred stock (resulting in a distribution of approximately $0.334375 per depositary share) and is payable on March 16, 2026 to the h

    2/19/26 4:30:00 PM ET
    $STT
    Major Banks
    Finance

    GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results

    Sold More Than 185,000 Galleri® Tests in 2025, Growing U.S. Galleri Revenue 26% Year-Over-Year to $136.8 MillionCompleted Galleri PMA Submission to FDAShared Topline Results from the NHS-Galleri TrialCompleted Analysis of the Full 35k Participant PATHFINDER 2 StudyStrong Financial Position with Cash into 2030MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (NASDAQ:GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the fourth quarter and full year 2025 and provided business updates.

    2/19/26 4:02:00 PM ET
    $GRAL
    Medical Specialities
    Health Care

    GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

    MENLO PARK, Calif., Feb. 16, 2026 /PRNewswire/ -- GRAIL, Inc. (NASDAQ:GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter and full year 2025 following the close of market on Thursday, Feb. 19, 2026. Following the release, company management will host a webcast and conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss results and business progress. Fourth Quarter and Full Year 2025 Webcast and Conference Call DetailsA link to the live webcast and recorded replay w

    2/16/26 9:00:00 AM ET
    $GRAL
    Medical Specialities
    Health Care